Podcasts about Rift Valley fever

Hemorrhagic virus? Check. Deadly disease? Check. Mosquito-borne? Check. Affected by animal movement, human activity, and environmental change? Check. Rift Valley Fever has all the markings of a classic TPWKY episode. This week, we're doing a deep dive on this deadly virus, taking a One Health approach to explore the intricate relationships between animals, humans, and the environment to understand how this virus moves across the landscape. We trace the various paths this virus takes: through the organisms it infects, across the globe as it spreads, and over time as it appears to be evolving to be deadlier. Tune in to learn more about Rift Valley fever and what we might see with this pathogen in the years to come. Support this podcast by shopping our latest sponsor deals and promotions at this link: https://bit.ly/3WwtIAu Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, Alex Drouin, an Expert in FAST Risk Management and Modelling Support at the EuFMD, introduces his research on "Rift Valley fever modeling in the Western Mediterranean basin" and the challenges of working with entomological data. The study focuses on the emergence of the Rift Valley fever virus in the Mediterranean region, emphasizing the risk of viral circulation, particularly in the Western Mediterranean basin. The research assesses the vector competence of key mosquito species and employs modeling to assess the spatio-temporal variations in the risk of virus transmission in the region.

Nelson Wandera is a physician in the infectious disease unit at Mbarara Regional Referral Hospital. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. N. Wandera and Others. Rift Valley Fever — The Need for an Integrated Response. N Engl J Med 2023;389:1829-1832.

GET HEIRLOOM SEEDS & NON GMO SURVIVAL FOOD HERE: https://heavensharvest.com/ USE Code WAM to get FREE shipping in the United States! GET AN EXTENDED FREE TRIAL FOR ICKONIC WHEN YOU SIGN UP HERE: https://www.ickonic.com/affiliate/josh10 HELP SUPPORT US AS WE DOCUMENT HISTORY HERE: https://gogetfunding.com/help-wam-cover-history/ GET YOUR APRICOT SEEDS at the life-saving Richardson Nutritional Center HERE: https://rncstore.com/r?id=bg8qc1 Josh Sigurdson reports on the news of a new endemic risk in the UK of mosquito borne diseases that risk killing 50% of people who get bit. This comes at the same time as the CDC warns of a totally different endemic string of diseases coming from the Gulf which just happens to ALSO risk 50% of people infected. So what is actually going on? We know that Bill Gates has been working on GMO mosquitoes that carry "vaccines" and diseases for nearly a decade and that this research has been sped up rapidly in the past 2 years, especially with the release of GMO mosquitoes in the Gulf throughout Florida. It just happens that wherever these mosquitoes are released, death follows. It is also important to note that these fake illnesses that are likely chemical injections can be used as an excuse for the mass die off which is increasing from the jabs. One this is for sure, there won't be an isolate and they won't give evidence for the specific illnesses, just like last time. The NHS notes that the mosquito borne illnesses are not something doctors can easily diagnose and that most people will have NO SYMPTOMS! The illnesses include Zika Virus which is an RNA strain, Crimean-Congo haemorrhagic fever, Rift Valley Fever among many others. And what's it being blamed on instead of the obvious release of GMO mosquitoes admittedly carrying diseases? Climate change. You can't make this up... But these psychopathic globalists figure they'll give it a try. Resist the tyranny in the coming lockdowns. They're trying to kill us. Protect yourself and your family. Disobey. Stay tuned for more from WAM! BUY GOLD AND SILVER HERE: https://kirkelliottphd.com/wam/ BUY YOUR PRIVATE CLEARPHONE HERE: https://www.r1kln3trk.com/3PC4ZXC/F9D3HK/ LION ENERGY: Never Run Out Of Power! PREPARE NOW! https://www.r1kln3trk.com/3PC4ZXC/D2N14D/ GET VITAMINS AND SUPPLEMENTS FROM DR. ZELENKO HERE: https://zstacklife.com/?ref=WAM GET TIM'S FREE Portfolio Review HERE: https://bit.ly/redpilladvisor And become a client of Tim's at https://www.TheLibertyAdvisor.com STOCK UP ON STOREABLE FOODS HERE: http://wamsurvival.com/ OUR GOGETFUNDING CAMPAIGN: https://gogetfunding.com/help-keep-wam-alive/ OUR PODBEAN CHANNEL: https://worldaltmedia.podbean.com/ Or SPOTIFY: https://open.spotify.com/show/5JWtlXypfL8iR8gGMg9MME Find us on Vigilante TV HERE: https://vigilante.tv/c/world_alternative_media/videos?s=1 FIND US on Rokfin HERE: https://rokfin.com/worldalternativemedia FIND US on Gettr HERE: https://www.gettr.com/user/worldaltmedia See our EPICFUNDME HERE: https://epicfundme.com/251-world-alternative-media JOIN OUR NEWSLETTER HERE: https://www.iambanned.com/ JOIN our Telegram Group HERE: https://t.me/worldalternativemedia JOIN US on Rumble Here: https://rumble.com/c/c-312314 FIND WAM MERCHANDISE HERE: https://teespring.com/stores/world-alternative-media FIND OUR CoinTree page here: https://cointr.ee/joshsigurdson JOIN US on SubscribeStar here: https://www.subscribestar.com/world-alternative-media We will soon be doing subscriber only content! Follow us on Twitter here: https://twitter.com/WorldAltMedia Help keep independent media alive! Pledge here! Just a dollar a month can help us alive! https://www.patreon.com/user?u=2652072&ty=h&u=2652072 BITCOIN ADDRESS: 18d1WEnYYhBRgZVbeyLr6UfiJhrQygcgNU World Alternative Media 2023

Exosomes are small vesicles that that facilitate communication between eukaryotic cells. They resemble mini-cells, and act like carrier pigeons, trafficking various “payloads” among cells. Dr. Ramin Hakami is a Professor of Microbiology at George Mason University. Dr. Hakami studies how infectious diseases are modulated by exosome signaling. Dr. Hakami talks about how exosomes can deliver messages to cells, how Rift Valley Fever and Plague affect exosome signaling within infected hosts, how exosomes provide specificity and a “reply all” function to signaling, how being in a Nobel lab affected his approach to science, and his alternate career as a salsa dancer.  This episode was supported by IV Rehydration Therapy, the treatment that prevents explosive diarrhea from inhibiting your social life. Participants: Karl Klose, Ph.D. (UTSA) Ramin Hakami, Ph.D. (George Mason University) Janakiram Seshu, Ph.D. (UTSA) Mylea Echazarreta (UTSA)

Livestock mobility plays an important role in the dissemination of major diseases in West Africa, including Foot-and-Mouth disease, Rift Valley Fever, and Peste des Petits Ruminants. There is a need to identify reliable predictors of livestock movements. So far, a majority of studies have focused on the analysis of static movement networks. We aimed at modelling the temporal dynamics of cattle and small ruminant movements in Senegal using a set of predictors: livestock market prices, rainfall, and biomass production.

The cross-border movement of animal pathogens can lead to dramatic social and economic consequences. Therefore countries implement prevention measures (e.g. surveillance, border controls and trade restrictions) to reduce the probability of entry of new pathogens. However, resources available for such risk mitigation measures are limited, especially considering the large number of potential source areas and different pathways of entry of the pathogens. We propose a simple and easy-to-use tool to monitor the risk of introduction of foot and mouth and similar transboundary (FAST) animal diseases (Peste des Petits Ruminants, Lumpy Skin Disease, Rift Valley Fever, Sheep and Goat Pox) with the aim of assisting health authorities to identify the most likely routes and source countries for the introduction of these diseases.

Peste des Petits Ruminants and Rift Valley Fever events 2020-2022 - V. Chevalier by European Commission for the Control of FMD

Peste des petits ruminants (PPR) and Rift Valley Fever are examples of transboundary animal diseases having major consequences in terms of health and economics. PPR is a highly pathogenic viral disease infecting principally sheep and goats, but also some wild artiodactyls, camelids and suids. This disease circulates in large parts of Africa, Asia, Eurasia and Middle-East and it has recently appeared at the gates of Europe in Georgia (2016) and Bulgaria (2018). A vaccine sxiste and the disease is the target of an eradication campaign by 2030. RVF is an arbovirus also affecting small ruminants and camelids, but also cattle and can be transmitted to human. The virus is transmitted among ruminants through the bite of infected mosquitoes (belonging to the Aedes and Culex species) and to human through the direct contact with infected blood or tissues. The disease circulates mostly in most countries in North, East, West and Sahelian Africa as well as in the Arabian Peninsula. Despite the different way of transmission, transboundary animal movement is the most likely route of the spread of the two diseases. Even though the livestock trade is strictly regulated between endemic regions of the two diseases and most of the Mediterranean countries, regional, locally adapted strategies are needed to control the diseases efficiently. The aim of this talk is to provide a panorama of the epidemiological situation around Europe and provide some preliminary scenario for the introduction of the diseases, through animal movement, and risk of transmission due to the presence of competent vectors (only for Rift Valley Fever).

In this week's episode we share some highligths from one our recent #FarmSpaces sessions about beekeeping!  Food For Mzansi's FarmSpaces host Gugulethu Mahlangu chats to a number of experts show share's some tips on how to get started. Before we let you go this week, new farmer's ever heard about Rift Valley Fever? It affects mainly sheep, cattle and buffalo. Symptoms include abortion storms and sudden death in young animals.  Dr Didi Claassen Afrivet's technical and marketing executive highlights some of the preventative measures farmer's should be aware of.

Craft beer popularity has skyrocketed over the past few years. If you want to get in on the craft beer trend we share a guide to getting started as a beer brewer on Farmer's Inside Track this week! FarmSol farming mentor Barry Nel, advises new farmers to be honest and hardworking to survive in the agri industry in our farmer development segment.  Ever heard of the Rift Valley Fever? Well, it affects mainly sheep, cattle and buffalo. Dr Didi Claassen Afrivet's technical and marketing executive joins us to share insights on how to deal with it.  When Dipitseng Manamela's environmental consultation business came to a standstill during covid-19 she chose to farm and this week she wears the crown as our #SoilSista, powered by Corteva Agriscience and Food For Mzansi. On the top of our reading list this week is, For the Love of Soil: Strategies to Regenerate our Food Production Systemby Nicole Masters. And, our farmer tip of the week comes from Western Cape crop farmer Sinethemba Botha…

Indian authorities have approved the world's first DNA-based Covid vaccine for emergency use. Not all the data that has led to the opening of the phase 3 trials is yet publicly available, but as public health policy expert Chandrakant Lahariya explains to presenter Roland Pease, it could be a real help in India's, and the world's, fight to get things under control. WHO Wuhan expedition The origins of the Covid virus were investigated last winter by a WHO team sent to Wuhan – where the first cases were discovered – earlier this year. Their work has since become the subject of intense political scrutiny and some criticism. This week, members of the team including Marian Koopmans have written a rebuttal, setting out the original terms of the investigation and urging the continuation of the process, as she explains to Victoria Gill. Decolonise Science Most of the science written by people from or about the African continent is written in English. Many local African languages do not currently have a meaningful vocabulary for many of the scientific terms and concepts researchers use. This week a team of scientists, journalists, and translators are completing the launch of a project called Decolonise Science, which will take 180 nominated papers posted on the website AfricaArxiv, translate them into 6 African languages including isiZulu, Sothu, and Hausa, and then use Machine Learning methods to build resources for science communication and education in people's home languages. Project partner Sibusiso Byela explains the thinking. Royal Society Africa Prize winner This week the UK's Royal Society announced its annual awards. Kenya's George Warimwe has taken the Africa Award for his work creating vaccines for a virus that creates disease in livestock and humans – Rift Valley Fever. His promising approach stems from years of working with adenovirus technology akin to the AstraZeneca Covid virus. But as he explains, his One Health approach is to learn from the immune response in humans and apply it to animals, and vice-versa. The grant associated with the award should also help him and his team pick- up on research left-off before the coronavirus pandemic. How did our ancestors sleep? How we sleep is a topic of endless fascination and for some can, ironically be quite exhausting. Modern life has allowed us to invade the night, and those pesky late night work emails, social media and TV all conspire to limit our sleep or simply prevent us from a truly restful night. But if we travel back in time, did our ancestors master sleep any better? No air-con or electric fan for them on hot humid nights, and only smoky fires to keep them warm on cold, snowy nights. What if we go way back into our pre-history, to our ancient human ancestors? No interruption for them from an unwanted work email, however perhaps a ravenous lion gave them more reason for those night time worries. CrowdScience listener Tom asks our sleep deprived presenter Datshiane Navanayagam to investigate how our sleep has changed over history and pre-history. She talks to Professor Russell Foster, Head of the Sleep and Circadian Neuroscience Institute at the University of Oxford and Neanderthal expert Dr Rebecca Wragg Sykes about slumber habits in days of yore, and in doing so, she uncovers some top tips from our ancestors that may give us all a better nights rest. (Image: Getty Images) Presenters: Roland Pease and Datshiane Navanayagam Producers: Alex Mansfield and Alexandra Feachem

Indian authorities have approved the world's first DNA-based covid vaccine for emergency use. Not all the data that has led to the opening of the phase 3 trials is yet publicly available, but as public health policy expert Chandrakant Lahariya explains to Roland, it could be a real help in India's, and the world's, fight to get things under control. The origins of the Covid virus were investigated last winter by a WHO team sent to Wuhan – where the first cases were discovered – earlier this year. Their work has since become the subject of intense political scrutiny and some criticism. This week, members of the team including Marian Koopmans have written a rebuttal, setting out the original terms of the investigation and urging the continuation of the process, as she explains to Victoria Gill. Most of the science written by people from or about the African continent is written in English. Many local African languages do not currently have a meaningful vocabulary for many of the scientific terms and concepts researchers use. This week a team of scientists, journalists, and translators are completing the launch of a project called Decolonise Science, which will take 180 nominated papers posted on the website AfricaArxiv, translate them into 6 African languages including isiZulu, Sothu, and Hausa, and then use Machine Learning methods to build resources for science communication and education in people's home languages. Project partner Sibusiso Byela explains the thinking. This week the UK's Royal Society announced its annual awards. Kenya's George Warimwe has taken the Africa Award for his work creating vaccines for a virus that creates disease in livestock and humans – Rift Valley Fever. His promising approach stems from years of working with adenovirus technology akin to the AstraZeneca covid virus. But as he explains, his One Health approach is to learn from the immune response in humans and apply it to animals, and vice-versa. The grant associated with the award should also help him and his team pick- up on research left-off before the coronavirus pandemic. (Image: Getty Images) Presenter: Roland Pease Producer: Alex Mansfield

Dr. Ayman Ahmed, a scientist at the University of Texas Medical Branch and a lecturer at the Institute of Endemic Diseases in Sudan, and Sarah Gregory discuss a unique outbreak of Rift Valley Fever in Sudan during 2019.

Earlier this week, senior members of former Sudan President Omar al-Bashir’s regime were reportedly diagnosed with the coronavirus and transferred from the notorious Kober prison to a hospital in Sudan’s capital city of Khartoum.It has put a spotlight on how the country’s health care system was laid to waste under Bashir’s regime, which was toppled and replaced by a civilian-led government last year.“Our public hospitals in Sudan over the past 30 years have deteriorated to the extent that they are hardly providing the regular health services to patients.”Nahla Gadalla, Sudanese American Medical Association“Our public hospitals in Sudan over the past 30 years have deteriorated to the extent that they are hardly providing the regular health services to patients,” said Nahla Gadalla, executive director of the Sudanese American Medical Association. “There’s no clear flow of information. It’s very hard for the central government, for the federal Ministry of Health to have the numbers or the data to support the decision-making.”Related: The State Dept. is nearing a deal over 1998 terrorism victims. But can Sudan pay it?Although the coronavirus was slow to reach Sudan in late March, it has already overwhelmed local health systems, leading to the closures of hospitals and health facilities. The virus has spread among health workers across the country.The African country reported 4,521 cases of the coronavirus and more than 200 deaths as of Friday.Gadalla, an infectious disease expert, notes the country was also dealing with back-to-back outbreaks of cholera and Rift Valley Fever in the months before COVID-19 hit.Limited financial resources and billions of dollars in debt have also hampered Sudan’s response to the coronavirus.Last month, United Nations High Commissioner for Human Rights Michelle Bachelet argued that sanctions, particularly those related to the US State Sponsors of Terrorism listing, were restricting Sudan from accessing IMF and World Bank funding for COVID-19 relief.“The only way Sudan will ever be able to break out of this cycle of poverty and desperation is to be freed from the impediments of sanctions imposed at the time of the previous government.” Michelle Bachelet, UN high commissioner for human rights “The only way Sudan will ever be able to break out of this cycle of poverty and desperation is to be freed from the impediments of sanctions imposed at the time of the previous government,” she said.“We are preparing a strategy to face coronavirus that extends until the end of June, but to execute it, we urgently need $120 million to provide protective equipment for health care workers and to prepare health care facilities and advanced lab testing equipment,” Sudan’s health minister, Akram Ali Altom, said in April.In addition to donations from other countries coming into Sudan, diaspora organizations such as SAMA are helping to fill the gap.Related: A year after revolution, Sudan celebrates but still faces squeeze of sanctionsBakri Ali, a businessman in Connecticut and a member of the University of Khartoum Alumni Association has played his part by fundraising to buy medical supplies like gloves and masks for the Ministry of Health.“It’s a slow process that takes days, and days, sometimes weeks, to transfer even $10,000,” he said, noting how years of sanctions and corruption have isolated Sudan’s economy from global banking and financing.

Welcome to Finance and Fury, The Furious Friday edition You probably are exhausted about the coronavirus - What you probably haven’t heard about is A little known type of bond created in 2017 by the World Bank. The World Bank – Headquartered in Washington DC – back in June 2017 – issued Pandemic Emergency Financing Facility (PEF) – call them pandemic bonds Technically their debt/lending arm – the International Bank for Reconstruction and Development Facility created by the World Bank to channel surge funding to developing countries facing the risk of a pandemic Is an international organisation created in 1944 – part of the Brenton woods era of creation of agencies The World Bank has two main goals: to end extreme poverty and promote shared prosperity – does this primarily by providing loans to its borrowing member government clients in middle-income countries Loans in the form of bonds – done so through the international capital markets for 70 years to fund its activities 2017 – the World Bank issued $425 million in a new type of “pandemic bonds” - Marks the first time that the World Bank is in the business of infectious diseases – with a maturity in just a few months – July 2020 Was oversubscribed by 200% - with investors eager to get their hands on the high-yield returns on offer World Bank Group President Jim Yong Kim said. “We are moving away from the cycle of panic and neglect that has characterized so much of our approach to pandemics. We are leveraging our capital market expertise, our deep understanding of the health sector, our experience overcoming development challenges, and our strong relationships with donors and the insurance industry to serve the world’s poorest people. This creates an entirely new market for pandemic risk insurance. I especially want to thank the World Health Organization and the governments of Japan and Germany for their support in launching this new mechanism.” How does it work - Investors buy the bonds and receive regular coupons payments in return but if there is an outbreak of disease, the investors don’t get their initial money back PEF financing to eligible countries will be triggered when an outbreak reaches predetermined levels of contagion, including number of deaths; the speed of the spread of the disease; and whether the disease crosses international borders. The determinations for the trigger are made based on data as reported by the World Health Organization (WHO) There are two varieties of debt, both scheduled to mature in July 2020. First bond raised $225 million - coupon rate of around 7% p.a. Payout on the bond is suspended if there is an outbreak of new influenza viruses or coronavirus (SARS, MERS). The second, riskier bond raised $95 million at an interest rate of more than 11%. This bond keeps investors’ money if there is an outbreak of Filovirus, Coronavirus, Lassa Fever, Rift Valley Fever, and/or Crimean Congo Hemorrhagic Fever. The World Bank also issued$105 million in swap derivatives that work in a similar way to protect the losses Done to attract a wider, more diverse set of investors – as it minimises the loses Countries eligible for financing under the PEF’s insurance window are members of the International Development Association (IDA) – an arm of the World Bank Group that provides finance for the world’s poorest countries The PEF, under its insurance window, has the capacity to provide payments up to a maximum of US$ 425 million during its initial 3-year period for all qualifying outbreaks combined But the catch is that there are established ceilings of maximum payments for each of the disease families covered. The maximum payout per disease is capped at US$275 million for pandemic Flu, US$150 million for Filovirus - but US$195.83 million for Coronavirus – less than half of funds raised Technical side to these bonds – in essence - are a combination of bonds and derivatives priced today (insurance window), along with a cash window, and future commitments from donor countries for additional coverage – convoluted and complex structure What are these windows - The PEF has two windows. The first is an ‘insurance’ window with premiums funded by Japan and Germany, consisting of bonds and swaps including those executed today. The bonds and derivatives for the PEF’s ‘insurance’ window were developed by the World Bank Treasury in cooperation with leading reinsurance companies Swiss Re and Munich Re - Swiss Re Capital Markets is the sole book-runner for the transaction Swiss Re Capital Markets Limited, Munich Re and GC Securities were also joint arrangers on the derivatives transactions. The bonds will be issued under IBRD’s “capital at risk” program because investors bear the risk of losing part or all of their investment in the bond if an epidemic event triggers pay-outs to eligible countries covered under the PEF. The second is a ‘cash’ window, for which Germany provided initial funding of Euro 50 million. The cash window will be available from 2018 for the containment of diseases that may not be eligible for funding under the insurance window.   A pandemic has been called - The premiums bondholders have received thus far were largely funded by the governments of Japan and Germany, with some from Australian Aid – seems like the taxpayers have been covering the costs of this – Like the whole funding for the WHObehind the United States and United Kingdom -but yet Reports have claimed that most of the bondholders are firms and individuals based in Europe – so using tax funds to pay the investors in these bonds Claims that investors who purchased those products could lose millions – Who bought these? - Asset managers – about 16% - Pension funds about 42% of the risky bonds – but the derivative positions should cover most But the individual list of bondholders are not publicly available – just the types of funds Market analysts and non-aligned economists have argued that these pandemic bonds were never intended to aid low-income pandemic-stricken countries - instead to enrich the financial sector American economic forecaster Martin Armstrong went on the record to call the World Bank’s pandemic bonds “a giant gamble in the global financial casino” – due to the derivative structures and counterparty risk - these bonds could present a structured derivative time bomb – all exploding at the same time the government controls around the pandemic are tanking markets    Armstrong went on to say that it is in WHO’s interest to declare the coronavirus outbreak a pandemic, but noted that, in doing so, they would cause bondholders to take a significant loss bottom of forms – but only if the derivatives don’t provide shift the risk to the counterparties Irony of this scheme - – ineffective for doing anything to reduce an outbreak – or provide funding in a timely manner These pandemic bonds fund created by the World Bank “to channel surge funding to developing countries facing the risk of a pandemic” and the creation of these so-called “pandemic bonds” was intended to transfer pandemic risk in low-income countries to global financial markets – remember this was the WHO who backed the World Bank’s initiative – as triggering a pandemic is in their authority Many policymakers have criticized the World Bank's pandemic bonds - Under their provisions, the bonds haven't yet made any payouts to threatened countries, because their terms require a waiting period of 12 weeks from when the triggering outbreak began Goes against what advocates said these pandemic bonds are meant to do. There was initially a belief that money would become rapidly available to countries early on in an outbreak If the goal was to stop a disease from spreading to new countries, then time was of the essence in setting a triggering event -- and unnecessary delays are incredibly counterproductive. Critics, however, have called the unnecessarily convoluted system “World-Bank-enabled looting” that enriches intermediaries and investors instead of the funds intended targets, in this case, low-income countries struggling to fight a pandemic. These critics have asked why not merely give these funds to a body like the Contingency Fund for Emergencies at the World Health Organization (WHO), where the funds could go directly to affected countries in need. Even Larry Summers, the former World Bank chief economist and the Secretary of the US Treasury who recommended sending garbage to poor countries dismissing the PEF as “financial goofiness.” The program was “designed to fail” because the bonds were crafted in order “to reduce the probability of payout but also limit the amount of funds to be paid out in an event to the derivative counterparties Current triggers guarantee that payouts will be too little because they kick in only after outbreaks grow large.   Summary  It appears that All of this was created to enrich financial speculators rather than just providing funding for an outbreak Anyway - Remember – the world bank ‘loans’ funds to third world nations – like all banks it isn’t a gift Gets these low-income nations in a position further indebtedness to the World Bank – denominated in USD So whilst the USD is surging right now due to the panic for people trying to get more of the reserve currency, the level of funds that have to be repaid grows Problem with this – we just have to take their word on it – there is zero evidence they actually do what they say – and they are the ones saying they do this Who knows if the money gets paid out or if it goes towards helping reduce the spread – as others have said – it is too little too late. Thank you for listening to today's episode. If you want to get in contact you can do so here: http://financeandfury.com.au/contact/

Dr. Chugtai reviews the family of Viral Hemorrhagic Fevers. He starts out by discussing transmission factors and major common symptoms for the class of disorders. He then covers the Bunyaviridae, including Hantavirus Pulmonary Syndrome and Rift Valley Fever. Dr. Chugtai then mentions the hemorrhagic fevers, including Ebola and Marburg viruses. Other hemorrhagic fevers dicussed includes Nipah virus disease and Hendra virus disease. Lastly, he discusses the flaviviruses, including Tick-borne encephalitis (TBE).

Clayton Willey, Professor of Pathology,
 UPMC Presbyterian Hospital Division of Neuropathology, Pittsburgh, USA, talks us through the recognition, referral and reporting of Rift Valley Fever. To learn more about Rift Valley Fever, visit BMJ Best Practice: https://bestpractice.bmj.com/topics/en-gb/1602 _ The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.

Veterinarian and epidemiologist Mathew Muturi tells how a Rift Valley Fever outbreak led to implementation of One Health-based policies. Muturi talks about his One Health training and its applications for health and biopreparedness. Julie’s Biggest Takeaways: One Health Simple communication between experts helps facilitate implementation of one health in public systems. Sitting experts in human and animal health in the same office allows easier communication between these different health sectors. One Health policies involving close collaboration between animal and human healthcare workers were first implemented in Kenya in response to the threat of avian influenza, but were discontinued after the threat waned. Human cases of Rift Valley Fever, due to spillover from a livestock outbreak, led to the discovery that these collaborative policies could prevent other outbreaks as well, and the policies were reinstated. Zoonotic diseases can often be the most overlooked. Officials of countries where endemic diseases are present may have preparedness plans for serious cases but may overlook something endemic like brucellosis. There are 42 subtribes in Kenya, including diverse languages, religions, and beliefs. Public health interventions do their best to align the local beliefs of the people to minimize risk of pathogen exposure. Featured Quotes: “One health is not a new concept; it’s an old concept that explains the health of humans, animals, and the environment is interconnected. It’s a concept that plays out in everyday life.” “One of the reasons One Health has been able to be successful in Kenya, and that I suggest to other countries wishing to implement this program, is the sitting together, talking together. Make sure that you work together, see each other - I don’t think communication works well enough if it’s on an ad hoc basis. The thing that has worked for us is sitting together.” “The most important aspect of One Health is the fact that that it’s impossible to control diseases that come from animals only by focusing on humans. It’s like trying to concentrate on putting out fires without ascertaining where the fires are coming from.” “Endemic diseases, despite the fact that they’re ever-present, are often the most ignored.” “A lot of the risk practices are cultural, and cultural change is very slow.” “The value of One Health is much more than the investment required to put into it. It’s one of the few things I’ve seen actually work in implementation of disease control strategies, in surveillance and in general disease control. It’s worked for Kenya and I believe it can work for all other countries.”   Links for the episode: Republic of Kenya Zoonotic Disease Unit Prioritization of Zoonotic Diseases in Kenya, 2015. Plos One.

Filmed live at ASM Biodefense 2016 with special guests: Rebekah Kading and Wyndham Lathem. From the ASM Biodefense and Emerging Diseases Research meeting, Vincent Racaniello speaks with Rebekah and Wyndham about their work on Rift Valley Fever virus and other vector-borne pathogens, and the evolution and pathogenesis of Yersinia pestis, the agent of plague. Links for this episode  Rift Valley fever virus risk (Emerg Micr Inf) Predicting Rift Valley fever virus transmission (PLoS NTD) Culex in New York City (BioOne) Early emergence of Y. pestis (Nature Comm) Pneumonic plague (Trends Micro) Music used on TWiM is composed and performed by Ronald Jenkees and used with permission. Don't miss an episode of MicrobeWorld Video. Subscribe for free using iTunes or help support our work by purchasing the MicrobeWorld podcast application for iPhone and Android devices in the iTunes or Android app stores. Send your microbiology questions and comments (email or mp3 file) to twim@twiv.tv, or call them in to 908-312-0760. You can also post articles that you would like us to discuss at microbeworld.org and tag them with twim. Subscribe to TWiM (free) on iTunes, Stitcher, Android, RSS, or by email. You can also listen on your mobile device with the Microbeworld app.

Filmed live at ASM Biodefense 2016 with special guests: Rebekah Kading and Wyndham Lathem. From the ASM Biodefense and Emerging Diseases Research meeting, Vincent Racaniello speaks with Rebekah and Wyndham about their work on Rift Valley Fever virus and other vector-borne pathogens, and the evolution and pathogenesis of Yersinia pestis, the agent of plague. See the video version at microbeworld.org/mwv

Filmed live at ASM Biodefense 2016 with special guests: Rebekah Kading and Wyndham Lathem. From the ASM Biodefense and Emerging Diseases Research meeting, Vincent Racaniello speaks with Rebekah and Wyndham about their work on Rift Valley Fever virus and other vector-borne pathogens, and the evolution and pathogenesis of Yersinia pestis, the agent of plague. Links for this episode  Rift Valley fever virus risk (Emerg Micr Inf) Predicting Rift Valley fever virus transmission (PLoS NTD) Culex in New York City (BioOne) Early emergence of Y. pestis (Nature Comm) Pneumonic plague (Trends Micro) Music used on TWiM is composed and performed by Ronald Jenkees and used with permission. Don't miss an episode of MicrobeWorld Video. Subscribe for free using iTunes or help support our work by purchasing the MicrobeWorld podcast application for iPhone and Android devices in the iTunes or Android app stores. Send your microbiology questions and comments (email or mp3 file) to twim@twiv.tv, or call them in to 908-312-0760. You can also post articles that you would like us to discuss at microbeworld.org and tag them with twim. Subscribe to TWiM (free) on iTunes, Stitcher, Android, RSS, or by email. You can also listen on your mobile device with the Microbeworld app.

Host: Vincent Racaniello Special guests: Rebekah Kading and Wyndham Lathem From the ASM Biodefense and Emerging Diseases Research meeting, Vincent speaks with Rebekah and Wyndham about their work on Rift Valley Fever virus and other vector-borne pathogens, and the evolution and pathogenesis of Yersinia pestis, the agent of plague. Subscribe to TWiM (free) on iTunes, Stitcher, Android, RSS, or by email. You can also listen on your mobile device with the Microbeworld app. Links for this episode  Rift Valley fever virus risk (Emerg Micr Inf) Predicting Rift Valley fever virus transmission (PLoS NTD) Culex in New York City (BioOne) Early emergence of Y. pestis (Nature Comm) Pneumonic plague (Trends Micro) Music used on TWiM is composed and performed by Ronald Jenkees and used with permission. Send your microbiology questions and comments (email or mp3 file) to twim@twiv.tv, or call them in to 908-312-0760. You can also post articles that you would like us to discuss at microbeworld.org and tag them with twim.

Dr George Warimwe talks about his research on Rift Valley Fever. Rift Valley Fever is a mosquito-borne virus, which affects both livestock and humans in Africa and parts of the Middle East. There is currently no licensed vaccine for use in humans. Amid fears that the virus may spread to Europe, Dr George Warimwe is working with the International Livestock Research Institute (ILRI) in Africa, and the Jenner Institute to develop a vaccine against Rift Valley Fever for both humans and livestock.

Dr George Warimwe talks about his research on Rift Valley Fever. Dr George Warimwe is working with the International Livestock Research Institute (ILRI) A Centre of Excellence in Africa, and the Jenner Institute to develop a vaccine against Rift Valley Fever in humans, that will also be useful as a vaccination against the disease in livestock.

Dr George Warimwe talks about his research on Rift Valley Fever. Dr George Warimwe is working with the International Livestock Research Institute (ILRI) A Centre of Excellence in Africa, and the Jenner Institute to develop a vaccine against Rift Valley Fever in humans, that will also be useful as a vaccination against the disease in livestock.

Dr George Warimwe talks about his research on Rift Valley Fever. Rift Valley Fever is a mosquito-borne virus, which affects both livestock and humans in Africa and parts of the Middle East. There is currently no licensed vaccine for use in humans. Amid fears that the virus may spread to Europe, Dr George Warimwe is working with the International Livestock Research Institute (ILRI) in Africa, and the Jenner Institute to develop a vaccine against Rift Valley Fever for both humans and livestock.

Background: The Rift Valley fever virus (RVFV) is an arthropod-borne phlebovirus. RVFV mostly causes outbreaks among domestic ruminants with a major economic impact. Human infections are associated with these events, with a fatality rate of 0.5-2%. Since the virus is able to use many mosquito species of temperate climates as vectors, it has a high potential to spread to outside Africa. Methodology/Principal Findings: We conducted a stratified, cross-sectional sero-prevalence survey in 1228 participants from Mbeya region, southwestern Tanzania. Samples were selected from 17,872 persons who took part in a cohort study in 2007 and 2008. RVFV IgG status was determined by indirect immunofluorescence. Possible risk factors were analyzed using uni-and multi-variable Poisson regression models. We found a unique local maximum of RVFV IgG prevalence of 29.3% in a study site close to Lake Malawi (N = 150). The overall seroprevalence was 5.2%. Seropositivity was significantly associated with higher age, lower socio-economic status, ownership of cattle and decreased with distance to Lake Malawi. A high vegetation density, higher minimum and lower maximum temperatures were found to be associated with RVFV IgG positivity. Altitude of residence, especially on a small scale in the high-prevalence area was strongly correlated (PR 0.87 per meter, 95% CI = 0.80-0.94). Abundant surface water collections are present in the lower areas of the high-prevalence site. RVF has not been diagnosed clinically, nor an outbreak detected in the high-prevalence area. Conclusions: RVFV is probably circulating endemically in the region. The presence of cattle, dense vegetation and temperate conditions favour mosquito propagation and virus replication in the vector and seem to play major roles in virus transmission and circulation. The environmental risk-factors that we identified could serve to more exactly determine areas at risk for RVFV endemicity.